Literature DB >> 17210808

Early recurrent ischemic lesions on diffusion-weighted imaging in symptomatic intracranial atherosclerosis.

Dong-Wha Kang1, Sun U Kwon, Sung-Hee Yoo, Kyum-Yil Kwon, Choong Gon Choi, Sang Joon Kim, Jae-Young Koh, Jong S Kim.   

Abstract

BACKGROUND: Prior observations have shown that early recurrent ischemic lesions (ERILs) on diffusion-weighted imaging occur frequently within the first week after an index stroke.
OBJECTIVE: To investigate differential patterns of ERILs among stroke subtypes, particularly intracranial large-artery atherosclerosis (IC-LAA).
DESIGN: Retrospective study.
SETTING: Tertiary university hospital. PATIENTS: We included 133 patients who experienced an acute ischemic stroke and who underwent initial diffusion-weighted imaging within 24 hours and subsequent diffusion-weighted imaging within 7 days after onset, and whose stroke subtype was IC-LAA, extracranial LAA (EC-LAA), or cardioembolism (CE). MAIN OUTCOME MEASURE: Early recurrent ischemic lesions were defined as new ischemic lesions on follow-up diffusion-weighted imaging, separate from the index stroke lesion.
RESULTS: Early recurrent ischemic lesions were observed in the following proportions: 50.9% (28/55) in the IC-LAA group, 47.4% (9/19) in the EC-LAA group, and 44.1% (26/59) in the CE group. Early recurrent ischemic lesions in the IC-LAA group had the following characteristics: (1) they occurred mostly (27 [96.4%] of 28) in the pial area of the same vascular territory as the index stroke; (2) they were more frequently observed in a higher grade of stenosis than in milder stenosis (P<.001), whereas ERILs in the EC-LAA group were not related to the degree of stenosis; (3) they were not associated with subsequent recanalization, whereas ERILs in the CE group were mostly associated with subsequent recanalization (P<.001); and (4) they were more closely associated with clinical recurrence than in the EC-LAA or CE group (P=.02).
CONCLUSION: Early recurrent ischemic lesions in the IC-LAA group are relatively frequent and have different patterns than in the EC-LAA or CE group.

Entities:  

Mesh:

Year:  2007        PMID: 17210808     DOI: 10.1001/archneur.64.1.50

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke.

Authors:  Dong-Wha Kang; Moon-Ku Han; Hye-Jin Kim; Hoyon Sohn; Bum Joon Kim; Sun U Kwon; Jong S Kim; Steven Warach
Journal:  Neurology       Date:  2015-12-18       Impact factor: 9.910

2.  Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.

Authors:  Jose G Romano; Shyam Prabhakaran; Azhar Nizam; Edward Feldmann; Rajbeer Sangha; George Cotsonis; Iszet Campo-Bustillo; Sebastian Koch; Tatjana Rundek; Marc I Chimowitz; David S Liebeskind
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-12-01       Impact factor: 2.136

3.  Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease.

Authors:  Shyam Prabhakaran; David S Liebeskind; George Cotsonis; Azhar Nizam; Edward Feldmann; Rajbeer S Sangha; Iszet Campo-Bustillo; Jose G Romano
Journal:  Stroke       Date:  2021-04-19       Impact factor: 10.170

4.  Long-term mortality according to the characteristics of early neurological deterioration in ischemic stroke patients.

Authors:  Young Dae Kim; Dongbeom Song; Eun Hye Kim; Ki Jeong Lee; Hye Sun Lee; Chung Mo Nam; Hyo Suk Nam; Ji Hoe Heo
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

Review 5.  Silent New Brain Lesions: Innocent Bystander or Guilty Party?

Authors:  Eun-Jae Lee; Dong-Wha Kang; Steven Warach
Journal:  J Stroke       Date:  2015-10-15       Impact factor: 6.967

6.  Neutrophil-to-lymphocyte ratio predicts early worsening in stroke due to large vessel disease.

Authors:  Ki-Woong Nam; Tae Jung Kim; Ji Sung Lee; Soo-Hyun Park; Hae-Bong Jeong; Byung-Woo Yoon; Sang-Bae Ko
Journal:  PLoS One       Date:  2019-08-26       Impact factor: 3.240

7.  Multiphase arterial spin labeling imaging to predict early recurrent ischemic lesion in acute ischemic stroke.

Authors:  Chi Kyung Kim; Chul-Ho Sohn; Ki-Woong Nam; Byung-Woo Yoon; Inpyeong Hwang
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

8.  Predictive Value of the ABCD3-I for Short- and Long-Term Stroke after TIA with or without sICAS.

Authors:  Xuewei Xie; Jing Jing; Xia Meng; Zixiao Li; Pan Chen; Xingquan Zhao; Yilong Wang; Liping Liu; Yong Jiang; Yuesong Pan; Aoming Jin; Hao Li; Yongjun Wang
Journal:  J Atheroscler Thromb       Date:  2021-11-06       Impact factor: 4.394

Review 9.  Recurrent stroke risk in intracranial atherosclerotic disease.

Authors:  Ahmad A Ballout; David S Liebeskind
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

10.  Effect and Safety of Rosuvastatin in Acute Ischemic Stroke.

Authors:  Ji Hoe Heo; Dongbeom Song; Hyo Suk Nam; Eung Yeop Kim; Young Dae Kim; Kyung-Yul Lee; Ki-Jeong Lee; Joonsang Yoo; Youn Nam Kim; Byung Chul Lee; Byung-Woo Yoon; Jong S Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.